| Year |
Citation |
Score |
| 2019 |
Donahue TJ, Webster KA, Hillhouse TM, De Oliveira EO, Porter JH. Discriminative stimulus properties of the typical antipsychotic haloperidol compared to other antipsychotic drugs in C57BL/6 mice. Behavioural Pharmacology. PMID 31058657 DOI: 10.1097/Fbp.0000000000000487 |
0.753 |
|
| 2018 |
Manvich DF, Webster KA, Foster SL, Farrell MS, Ritchie JC, Porter JH, Weinshenker D. The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice. Scientific Reports. 8: 3840. PMID 29497149 DOI: 10.1038/S41598-018-22116-Z |
0.722 |
|
| 2017 |
Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH. Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice. Psychopharmacology. PMID 28921163 DOI: 10.1007/S00213-017-4738-Y |
0.754 |
|
| 2017 |
Porter JH, Webster KA, Prus AJ. Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic Drugs. Current Topics in Behavioral Neurosciences. PMID 28341945 DOI: 10.1007/7854_2017_4 |
0.755 |
|
| 2017 |
Porter JH, Manvich DF, Webster KA, Foster SL, Farrell MS, Weinshenker D. Behavioral and Pharmacokinetic Properties of the Putatively-Inert DREADD Ligand Clozapine-N-Oxide (CNO) in Rats and Mice The Faseb Journal. 31. DOI: 10.1096/Fasebj.31.1_Supplement.Lb594 |
0.637 |
|
| 2016 |
Farrell MS, McCorvy JD, Huang XP, Urban DJ, White KL, Giguere PM, Doak AK, Bernstein AI, Stout KA, Park SM, Rodriguiz RM, Gray BW, Hyatt WS, Norwood AP, Webster KA, et al. In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. Plos One. 11: e0150602. PMID 26963248 DOI: 10.1371/Journal.Pone.0150602 |
0.547 |
|
| 2014 |
Donahue TJ, Hillhouse TM, Webster KA, Young R, De Oliveira EO, Porter JH. (S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics. European Journal of Pharmacology. 734: 15-22. PMID 24726559 DOI: 10.1016/J.Ejphar.2014.03.047 |
0.757 |
|
| 2013 |
Webster K, Hillhouse T, Donahue T, Friar M, Joseph B, Beardsley P, Windle J, Stewart J, Porter J. A.10 - EFFECTS OF D-AMPHETAMINE IN VESICULAR MONOAMINE TRANSPORTER (VMAT)1 KNOCKOUT MICE SUGGEST A SCHIZOPHRENIC PHENOTYPE IN CONDITIONED AND UNCONDITIONED BEHAVIOR Behavioural Pharmacology. 24: e25. DOI: 10.1097/01.Fbp.0000434771.21238.50 |
0.734 |
|
| 2013 |
Donahue TJ, Webster KA, Hillhouse TM, Friar MA, De Oliveria EO, Porter JH. A.4 - A COMPARISON OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE AND THE TYPICAL ANTIPSYCHOTIC HALOPERIDOL IN C57BL/6 MICE Behavioural Pharmacology. 24: e23. DOI: 10.1097/01.Fbp.0000434765.90743.6C |
0.75 |
|
| 2011 |
Wiebelhaus JM, Webster KA, Meltzer HY, Porter JH. The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice. Behavioural Pharmacology. 22: 458-67. PMID 21712711 DOI: 10.1097/Fbp.0B013E328348Ec4F |
0.714 |
|
| Show low-probability matches. |